Sputum eosinophil counts in a large population of mild-to-moderate asthmatics: distribution, relationship with methacholine bronchial responsiveness and influence of a regular treatment with low doses of inhaled corticosteroids
R. E. Louis, P. Blaise, J. Sele, M. Henket, D. Cataldo, J. Bettiol, P. Bartsch (Liege, Belgium)
Source: Annual Congress 2001 - Molecular and cellular pathology of asthma
Session: Molecular and cellular pathology of asthma
Session type: Poster Discussion
Number: 3564
Disease area: Airway diseases
Abstract Airway eosinophilia is a feature of asthma thought to play a functional role in the disease. However data on the proportion of asthmatics exhibiting raised airway eosinophilia are still lacking. We have assessed the sputum eosinophil count and its relationship with methacholine bronchial responsiveness in 118 consecutive mild to moderate steroid naive asthmatics recruited from our outpatient clinic and compared the results with those found in 44 asthmatics treated with low to moderate doses of inhaled steroids (200-800 μg/d) and 44 healthy non atopic subjects. Steroid naive asthmatics differentiated from healthy subjects (p<0.001) and steroid treated asthmatics (p<0.05) by an increased sputum eosinophil counts expressed both as a percentage or as absolute values. The mean±]SD and median (range) of the percentage of sputum eosinophils were 10.9±]13.6% and 4.8%(0-75) in steroid naive asthmatics, 5.8±]10% and 1.8%(0-47.5) in steroid treated patients and 0.3±]0.6% and 0%(0-2.3)in healthy subjects respectively. Based on the values of our healthy group, 82% of steroid naive asthmatics had abnormally raised sputum eosinophil count (>1.5%) while this proportion reached 64% in steroid treated patients. In steroid naive patients the sputum eosinophil count significantly contributed to methacholine bronchial hyperresponsiveness accounting for 15% of the variation in PC20M while the relationship was longer significant in steroid treated patients. We conclude that the large majority of mild to moderate asthmatics had increased sputum eosinophilia that plays a limited role in determining the degree of methacholine airway hyperresponsiveness which is only evident in steroid naive patients.
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. E. Louis, P. Blaise, J. Sele, M. Henket, D. Cataldo, J. Bettiol, P. Bartsch (Liege, Belgium). Sputum eosinophil counts in a large population of mild-to-moderate asthmatics: distribution, relationship with methacholine bronchial responsiveness and influence of a regular treatment with low doses of inhaled corticosteroids. Eur Respir J 2001; 16: Suppl. 31, 3564
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Does sputum eosinophil counts predict the response to inhaled corticosteroids in terms of methacholine bronchial responsiveness in steroid naive asthmatics? Source: Eur Respir J 2001; 18: Suppl. 33, 336s Year: 2001
Assessment and evaluation of symptomatic steroid-naive asthmatics without sputum eosinophilia and their response to inhaled corticosteroids Source: Eur Respir J 2002; 20: 1364-1369 Year: 2002
High sputum eosinophils are associated with better response to inhaled corticosteroids in asthmatic patients Source: Eur Respir J 2002; 20: Suppl. 38, 113s Year: 2002
Longitudinal change in bronchial responsiveness in patients with cough variant asthma and the effect of inhaled corticosteroids Source: Eur Respir J 2004; 24: Suppl. 48, 587s Year: 2004
One year monitoring of children with bronchial asthma and other allergic diseases treated with inhaled corticosteroids vs cromoglycates with serum ECP (S-ECP), FEV1, total IgE and blood eosinophil count - the influence of different therapy Source: Eur Respir J 2002; 20: Suppl. 38, 432s Year: 2002
Influence of large and small dose of fluticasone propionate on clinical symptoms of bronchial asthma, lung function, bronchial hyperreactivity and eosinophilia in induced sputum Source: Eur Respir J 2002; 20: Suppl. 38, 111s Year: 2002
Absence of sputum eosinophils in subjects with symptomatic asthma on inhaled budesonide Source: Eur Respir J 2002; 20: Suppl. 38, 274s Year: 2002
Effect of salmeterol in asthmatic patients with low sputum eosinophils Source: Eur Respir J 2001; 18: Suppl. 33, 336s Year: 2001
Relationships of mannitol challenge to methacholine challenge and inflammatory markers in asthmatics receiving inhaled corticosteroids Source: Annual Congress 2012 - Bronchial challenge as a biomarker of respiratory disease Year: 2012
Induced sputum in children with persistent asthma: the effect of inhaled corticosteroid treatment Source: Eur Respir J 2006; 28: Suppl. 50, 258s Year: 2006
Regular salbutamol use increases CXCL8 responses in asthma: relationship to the eosinophil response Source: Eur Respir J 2003; 22: 118-126 Year: 2003
Blood eosinophils as a marker of response to inhaled corticosteroids in COPD Source: Eur Respir J 2016; 47:1374-1382 Year: 2016
The effect of inhaled corticosteroids on airway hyperresponsiveness to mannitol in patients with Type 2 low asthma Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma Year: 2020
The effects of two weeks of repeated low-dose allergen exposure on sputum eosinophilic and neutrophilic inflammation in atopic asthma: protection by inhaled steroids? Source: Eur Respir J 2001; 18: Suppl. 33, 482s Year: 2001
Symptoms, induced sputum eosinophil percentages and treatment with salmeterol or fluticasone in mild asthmatics Source: Eur Respir J 2001; 18: Suppl. 33, 336s Year: 2001
Evaluation of the association between eosinophil variability and effects of inhaled corticosteroids in COPD patients using propensity score matching Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more Year: 2019
The effects of inhaled steroids, leukotriene receptor antagonists and theophylline on induced sputum cell counts, serum and sputum ECP levels in mild persistent asthma Source: Eur Respir J 2001; 18: Suppl. 33, 261s Year: 2001
Cytokines concentrations in induced sputum of mild COPD patients. Correlation to clinical response to inhaled corticosteroids Source: Eur Respir J 2002; 20: Suppl. 38, 309s Year: 2002
The effect of inhaled corticosteroids on airway mast cells in type 2 low asthma Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights Year: 2020
Induced sputum in children with mild-moderate persistent asthma: the effect of inhaled corticosteroid treatment Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008